Effects of levodopa on pulmonary function in Parkinson's disease.
Identifieur interne : 003B49 ( Main/Merge ); précédent : 003B48; suivant : 003B50Effects of levodopa on pulmonary function in Parkinson's disease.
Auteurs : B. Herer [France] ; I. Arnulf ; B. HoussetSource :
- Chest [ 0012-3692 ] ; 2001.
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Airway Obstruction (complications), Antiparkinson Agents (pharmacology), Cross-Over Studies, Double-Blind Method, Female, Humans, Levodopa (pharmacology), Male, Middle Aged, Parkinson Disease (complications), Parkinson Disease (physiopathology), Respiratory Function Tests, Respiratory Mechanics (drug effects), Spirometry.
- MESH :
- chemical , pharmacology : Antiparkinson Agents, Levodopa.
- complications : Airway Obstruction, Parkinson Disease.
- drug effects : Respiratory Mechanics.
- physiopathology : Parkinson Disease.
- Aged, Aged, 80 and over, Cross-Over Studies, Double-Blind Method, Female, Humans, Male, Middle Aged, Respiratory Function Tests, Spirometry.
Abstract
Upper-airway obstruction (UAO) may be present in patients with Parkinson's disease (PD), and its reversibility after levodopa therapy has been suggested. To investigate the effects of oral intake of levodopa on pulmonary function and UAO criteria in patients with PD, we studied 22 patients with PD.
PubMed: 11171713
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001261
- to stream PubMed, to step Curation: 001220
- to stream PubMed, to step Checkpoint: 001220
- to stream Ncbi, to step Merge: 000162
- to stream Ncbi, to step Curation: 000162
- to stream Ncbi, to step Checkpoint: 000162
Links to Exploration step
pubmed:11171713Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effects of levodopa on pulmonary function in Parkinson's disease.</title><author><name sortKey="Herer, B" sort="Herer, B" uniqKey="Herer B" first="B" last="Herer">B. Herer</name><affiliation wicri:level="1"><nlm:affiliation>Service de Pneumologie, Centre Médical de Forcilles, Férolles-Attilly, France. HBherer@aol.com</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Pneumologie, Centre Médical de Forcilles, Férolles-Attilly</wicri:regionArea><wicri:noRegion>Férolles-Attilly</wicri:noRegion><wicri:noRegion>Férolles-Attilly</wicri:noRegion></affiliation></author><author><name sortKey="Arnulf, I" sort="Arnulf, I" uniqKey="Arnulf I" first="I" last="Arnulf">I. Arnulf</name></author><author><name sortKey="Housset, B" sort="Housset, B" uniqKey="Housset B" first="B" last="Housset">B. Housset</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2001">2001</date><idno type="RBID">pubmed:11171713</idno><idno type="pmid">11171713</idno><idno type="wicri:Area/PubMed/Corpus">001261</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001261</idno><idno type="wicri:Area/PubMed/Curation">001220</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001220</idno><idno type="wicri:Area/PubMed/Checkpoint">001220</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001220</idno><idno type="wicri:Area/Ncbi/Merge">000162</idno><idno type="wicri:Area/Ncbi/Curation">000162</idno><idno type="wicri:Area/Ncbi/Checkpoint">000162</idno><idno type="wicri:doubleKey">0012-3692:2001:Herer B:effects:of:levodopa</idno><idno type="wicri:Area/Main/Merge">003B49</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Effects of levodopa on pulmonary function in Parkinson's disease.</title><author><name sortKey="Herer, B" sort="Herer, B" uniqKey="Herer B" first="B" last="Herer">B. Herer</name><affiliation wicri:level="1"><nlm:affiliation>Service de Pneumologie, Centre Médical de Forcilles, Férolles-Attilly, France. HBherer@aol.com</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Pneumologie, Centre Médical de Forcilles, Férolles-Attilly</wicri:regionArea><wicri:noRegion>Férolles-Attilly</wicri:noRegion><wicri:noRegion>Férolles-Attilly</wicri:noRegion></affiliation></author><author><name sortKey="Arnulf, I" sort="Arnulf, I" uniqKey="Arnulf I" first="I" last="Arnulf">I. Arnulf</name></author><author><name sortKey="Housset, B" sort="Housset, B" uniqKey="Housset B" first="B" last="Housset">B. Housset</name></author></analytic><series><title level="j">Chest</title><idno type="ISSN">0012-3692</idno><imprint><date when="2001" type="published">2001</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Airway Obstruction (complications)</term><term>Antiparkinson Agents (pharmacology)</term><term>Cross-Over Studies</term><term>Double-Blind Method</term><term>Female</term><term>Humans</term><term>Levodopa (pharmacology)</term><term>Male</term><term>Middle Aged</term><term>Parkinson Disease (complications)</term><term>Parkinson Disease (physiopathology)</term><term>Respiratory Function Tests</term><term>Respiratory Mechanics (drug effects)</term><term>Spirometry</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiparkinson Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Airway Obstruction</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Respiratory Mechanics</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Cross-Over Studies</term><term>Double-Blind Method</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Respiratory Function Tests</term><term>Spirometry</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Upper-airway obstruction (UAO) may be present in patients with Parkinson's disease (PD), and its reversibility after levodopa therapy has been suggested. To investigate the effects of oral intake of levodopa on pulmonary function and UAO criteria in patients with PD, we studied 22 patients with PD.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003B49 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 003B49 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Main
|étape= Merge
|type= RBID
|clé= pubmed:11171713
|texte= Effects of levodopa on pulmonary function in Parkinson's disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:11171713" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonFranceV1
| This area was generated with Dilib version V0.6.29. |  |